Jbf Capital, Inc. Brickell Biotech, Inc. Call Options Transaction History
Jbf Capital, Inc.
- $630 Million
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BBI
# of Institutions
1Shares Held
65KCall Options Held
0Put Options Held
0About Brickell Biotech, Inc.
- Ticker BBI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,873,960
- Market Cap $6.75M
- Description
- Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops sofpironium bromide, which has completed Phase III clinical trials for the treatment of primary ...